← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Mitochondria In Motion, Inc.
Saint Louis, MO
$4,727,501
Total funding
4
Grants
Funding over time
peak $1.9M · FY2019–23$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$4,727,501 · 4
By mechanism
R42$3,915,859 · 2
R41$811,642 · 2
Investigators at Mitochondria In Motion, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Mitofusin agonists to prevent Charcot-Marie-Tooth disease 2A$1,059,214
R42 · FY2021 · NS
Mitofusin Agonists to Treat Neurodegenerative Disease$986,168
R42 · FY2023 · NS
Mitofusin Agonists to Treat Neurodegenerative Disease$968,715
R42 · FY2022 · NS
Mitofusin agonists to prevent Charcot-Marie-Tooth disease 2A$901,762
R42 · FY2022 · NS
Mitofusin agonists to prevent Charcot-Marie-Tooth disease 2A$254,379
R41 · FY2019 · NS
MITOFUSIN AGONISTS TO TREAT NEURODEGENERATIVE DISEASE$254,062
R41 · FY2019 · NS
MITOFUSIN AGONISTS TO TREAT NEURODEGENERATIVE DISEASE$224,701
R41 · FY2020 · NS
MITOFUSIN AGONISTS TO TREAT NEURODEGENERATIVE DISEASE$78,500
R41 · FY2021 · NS